Total Funding
83
69
Total FundingPost-IPO Debt raised
Growth Score 83 in past quarter
-5 pts
Heat Score 69 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
22855
Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.
Richard Lindahl: Executive Vice President & Chief Financial OfficerPast Role: SprintFeed, Senior Vice President & Treasurer- Zach Wolff: Director, Sales and Business Development, CDMOPast Role: Exigence Technologies, Co-Founder and CEO
About the Company
Emergent BioSolutions is a global life sciences company that is driven by a mission to protect and enhance life. It develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases.
The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.
